Trademark Overview
On Tuesday, May 16, 2023, a trademark application was filed for NETWORK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NETWORK THERAPEUTICS trademark a serial number of 97939307. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, March 15, 2024. This trademark is owned by Sonata Therapeutics, Inc.. The NETWORK THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation; scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others; te...
